These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 10783345

  • 21. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R.
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [Abstract] [Full Text] [Related]

  • 22. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Witz CA, Daftary GS, Doody KJ, Park JK, Seifu Y, Yankov VI, Heiser PW, Menopur in GnRH Antagonist Cycles with Single Embryo Transfer – High Responder (MEGASET-HR) Trial Group.
    Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
    [Abstract] [Full Text] [Related]

  • 23. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N, van Wely M, van Der Veen F.
    Cochrane Database Syst Rev; 2001 Aug; (2):CD002121. PubMed ID: 11406034
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.
    Pacchiarotti A, Aragona C, Gaglione R, Selman H.
    J Assist Reprod Genet; 2007 Sep; 24(9):400-5. PubMed ID: 17653846
    [Abstract] [Full Text] [Related]

  • 25. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.
    Selman HA, De Santo M, Sterzik K, Coccia E, El-Danasouri I.
    Fertil Steril; 2002 Nov; 78(5):1061-7. PubMed ID: 12413994
    [Abstract] [Full Text] [Related]

  • 26. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC.
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [Abstract] [Full Text] [Related]

  • 27. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.
    Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
    van Wely M, Westergaard LG, Bossuyt PM, van der Veen F.
    Fertil Steril; 2003 Nov; 80(5):1086-93. PubMed ID: 14607553
    [Abstract] [Full Text] [Related]

  • 29. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
    Westergaard LG, Yding Andersen C, Erb K, Laursen SB, Rasmussen PE, Rex S, Teisner B.
    Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294
    [Abstract] [Full Text] [Related]

  • 30. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM.
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [Abstract] [Full Text] [Related]

  • 31. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M.
    Reprod Biol Endocrinol; 2006 Jul 18; 4():38. PubMed ID: 16848893
    [Abstract] [Full Text] [Related]

  • 32. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F.
    Cochrane Database Syst Rev; 2003 Jul 18; (1):CD003973. PubMed ID: 12535497
    [Abstract] [Full Text] [Related]

  • 33. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles.
    Yang C, Dong N, Li F, Ji Y, Pan Y, She H.
    J Ovarian Res; 2022 Jun 21; 15(1):74. PubMed ID: 35729654
    [Abstract] [Full Text] [Related]

  • 34. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J, Fábregues F, Creus M, Moreno V, Puerto B, Peñarrubia J, Carmona F, Vanrell JA.
    Hum Reprod; 1996 Nov 21; 11(11):2400-4. PubMed ID: 8981119
    [Abstract] [Full Text] [Related]

  • 35. Addition of low-dose hCG to rFSH during ovarian stimulation for IVF/ICSI: is it beneficial?
    Partsinevelos GA, Antonakopoulos N, Kallianidis K, Drakakis P, Anagnostou E, Bletsa R, Loutradis D.
    Clin Exp Obstet Gynecol; 2016 Nov 21; 43(6):818-825. PubMed ID: 29944230
    [Abstract] [Full Text] [Related]

  • 36. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A, Gurgan T.
    Hum Reprod; 2007 Jan 21; 22(1):97-100. PubMed ID: 16954409
    [Abstract] [Full Text] [Related]

  • 37. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H, Huang G, Pei L, Zeng P, Luo X.
    Gynecol Endocrinol; 2012 Jul 21; 28(7):540-4. PubMed ID: 22390186
    [Abstract] [Full Text] [Related]

  • 38. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J, Antaki R, Kadoch IJ, Dean NL, Sylvestre C, Bissonnette F, Benoit J, Ménard S, Lapensée L.
    Fertil Steril; 2015 Dec 21; 104(6):1419-25. PubMed ID: 26361207
    [Abstract] [Full Text] [Related]

  • 39. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S.
    Hum Reprod; 1996 Jun 21; 11(6):1209-13. PubMed ID: 8671425
    [Abstract] [Full Text] [Related]

  • 40. The influence of gonadotropins on clinico-biological ICSI outcome: a retrospective comparative study rFsH vs HP-hmg.
    Khlifi A, Kacem O, Maroueni M, Elgoul L, Hidar S, Fekih M, Boughizane S, Essaidi H, Ben Regaya L, Bibi M, Ajina M, Khairi H.
    Tunis Med; 2016 Jun 21; 94(6):167-177. PubMed ID: 28051220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.